Cargando…
Host‐directed therapy to combat mycobacterial infections
Upon infection, mycobacteria, such as Mycobacterium tuberculosis (Mtb) and nontuberculous mycobacteria (NTM), are recognized by host innate immune cells, triggering a series of intracellular processes that promote mycobacterial killing. Mycobacteria, however, have developed multiple counter‐strategi...
Autores principales: | Kilinç, Gül, Saris, Anno, Ottenhoff, Tom H. M., Haks, Mariëlle C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248113/ https://www.ncbi.nlm.nih.gov/pubmed/33565103 http://dx.doi.org/10.1111/imr.12951 |
Ejemplares similares
-
Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium
por: Kilinç, Gül, et al.
Publicado: (2022) -
The role of donor‐unrestricted T‐cells, innate lymphoid cells, and NK cells in anti‐mycobacterial immunity
por: Ruibal, Paula, et al.
Publicado: (2021) -
Iminosugars: A host-targeted approach to combat Flaviviridae infections
por: Evans DeWald, Lisa, et al.
Publicado: (2020) -
Leptin mutation and mycobacterial infection lead non-synergistically to a similar metabolic syndrome
por: Ding, Yi, et al.
Publicado: (2022) -
Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances in vitro and in vivo Anti-mycobacterial Activity in Human Macrophages and in Zebrafish
por: Moreira, Jôsimar D., et al.
Publicado: (2020)